Global aminoglycoside market is expected to reach USD 1.68 billion by 2022 growing at an estimated CAGR of 3.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the increasing incidences of animal disease outbreaks leading to high utilization of antibiotics.
However, reduction in prescription rate of aminoglycoside antibiotics due to side effects associated with usage of these drugs that include severe ototoxicity, nephrotoxicity, and neuromuscular blockade are expected to affect the market growth negatively. Furthermore, regulatory disapproval for the usage of certain aminoglycoside in regions is also anticipated to attribute for subordinate growth in this industry.
To request a sample copy or view summary of this report, click the link below:
Further key findings from the report suggest:
Grand View Research has segmented aminoglycoside market on the basis of product, route of administration, application, and region:
Aminoglycoside Product Outlook (Market Revenue in USD Million, 2012 - 2022 )
Aminoglycoside Outlook, by Route of Administration (Market Revenue in USD Million, 2012 - 2022)
Aminoglycoside Application Outlook (Market Revenue in USD Million, 2012 - 2022)
UTI & Pelvic Diseases
Aminoglycoside Regional Outlook (Revenue, USD Million, 2012 - 2022)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.